Bumper Offer - Urjas oil Just @ Rs. 1
Cosvate NM Cream 15gm is a prescription drug, available for use as Cream. Primarily, it is used for the treatment of Psoriasis, Eczema, Dermatitis. Other than this, Cosvate NM Cream 15gm has some other therapeutic uses, which have been discussed ahead.
The right dosage of Cosvate NM Cream 15gm depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Cosvate NM Cream 15gm have been listed ahead. Normally, these side effects of Cosvate NM Cream 15gm are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Cosvate NM Cream 15gm's effect is Moderate during pregnancy and Mild for lactating mothers. In addition, Cosvate NM Cream 15gm's effects on the liver, heart and kidney are discussed below in the Cosvate NM Cream 15gm related warnings section.
The section on Cosvate NM Cream 15gm contraindications lists all such conditions.
Besides this, Cosvate NM Cream 15gm may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Cosvate NM Cream 15gm is safe while driving, and is is addictive in nature.
Cosvate NM Cream 15gm is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Cosvate NM Cream 15gm is used -
Moderate
Mild
Is the use of Cosvate NM Cream 15gm safe for pregnant women?
Cosvate can have harmful effects in pregnant women. If you experience any discomfort after using Cosvate, then discontinue the use and take your doctor's advice.
Is the use of Cosvate NM Cream 15gm safe during breastfeeding?
Cosvate has been seen to have minimal side effects on breastfeeding women.
What is the effect of Cosvate NM Cream 15gm on the Kidneys?
There are no side effects of Cosvate on the kidneys.
What is the effect of Cosvate NM Cream 15gm on the Liver?
There are no any side effects of Cosvate on the liver.
What is the effect of Cosvate NM Cream 15gm on the Heart?
There are no any side effects of Cosvate for the heart.
Cosvate NM Cream 15gm should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Cosvate NM Cream 15gm unless your doctor advises you to do so -
Is this Cosvate NM Cream 15gm habit forming or addictive?
No, you will not get addicted to Cosvate NM Cream 15gm.
Is it safe to drive or operate heavy machinery when consuming?
Cosvate NM Cream 15gm will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Cosvate NM Cream 15gm is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Cosvate NM Cream 15gm is unable to treat or cure mental disorders.
Interaction between Food and Cosvate NM Cream 15gm
Information is not available on the interaction of any foods with Cosvate NM Cream 15gm, due to a lack of research on this.
Interaction between Alcohol and Cosvate NM Cream 15gm
It is difficult to say anything about the effect of Cosvate NM Cream 15gm and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vusion® (miconazole nitrate, zinc oxide, and white petrolatum)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-139
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 750
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neo-Fradin (neomycin sulfate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895